Physician profile
Ellen C Rowe
NPI 1598260580
$681.36
in general payments reported to CMS, 2019-2025
11 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.94 · 2021: $92.19 · 2022: $180 · 2023: $129 · 2024: $162 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326 · Education: $67.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.83 |
| Education | $67.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $146.01 | 2023-2025 | Veozah |
| Amgen INC. | $137.01 | 2022-2024 | Repatha, Otezla |
| Novo Nordisk INC | $107.65 | 2021-2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.19 | 2021-2022 | |
| Lilly USA, LLC | $73.70 | 2022-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $35.05 | 2021-2022 | |
| Abbvie INC. | $34.59 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.50 | 2024 | Airsupra |
| Watermark Medical, INC. | $15.29 | 2024 | |
| Coopersurgical, INC. | $14.94 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.